100
Participants
Start Date
April 16, 2018
Primary Completion Date
March 31, 2020
Study Completion Date
June 30, 2020
Dimethandrolone-Undecanoate
Single doses of DMAU in castor oil/benzyl benzoate administered in 100 mg capsules.
Levonorgestrel 0.03 MG
Single doses of LNG administered in 30 mcg capsules.
Placebo oral capsule
Placebo capsules that look like DMAU and LNG capsules but with no active ingredients.
RECRUITING
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance
RECRUITING
University of Washington Medical Center & Health Sciences, Seattle
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
OTHER
University of Washington
OTHER
Premier Research
OTHER